First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
AM Best's News Service interviewed Mitchell's Michele Hibbert-Iacobacci about how the COVID-19 pandemic is affecting the workers' compensation indu
The Whole Person ApproachIn the last five years terms such as advocacy, engagement, coaching, and even “whole-person approach” have been m
Over the past several months, the Mitchell | Genex teams have been closely monitoring the developments surrounding COVID-19 and the CDC’s recommend
Mitchell Senior Vice President of Regulatory Compliance Management Michele Hibbert-Iacobacci shared her thoughts and expertise with Claims Journal